Evaluation of Post-Translation Control Mechanisms (Mirnas) In Type 1 Diabetic Patients with and Without Cardiac Autonomic Neuropathy

Volume 2 - Issue 5

Ewa Tobor¹, Anna Polus², Joanna Gastol¹, Bartlomiej Matejko^1,3, Lukasz Pawlinski¹ and Beata Kiec Wilk^1,3*

• ¹University Hospital, Krakow, Poland
• ²Department of Clinical Biochemistry, Jagiellonian University Medical, Poland
• ³Department of Metabolic Diseases, Jagiellonian University Medical College, Poland

Received: March 17, 2020;   Published: April 06, 2020

*Corresponding author: Beata Kiec Wilk, Department of Metabolic Diseases Jagiellonian University, Medical College, M Jakubowskiego, Krakow Poland

DOI: 10.32474/SJFN.2020.02.000150

 

FullText PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Introduction: Type 1 diabetes (T1DM) is a chronic disease with multifactor pathogenesis. Large number of studies confirmed that epigenetic, microRNA (miRNA)- mediated, regulation mechanisms of gene expression are associated with both pathogenesis of T1DM and the progression of its complications. Cardiac autonomic neuropathy (CAN), the microvascular complication, is one of the strongest risk factor of cardiac mortality among T1DM patients. Circulating miRNA might be a predictor of development and progression of this diabetic complication but studies concerning connection between miRNA and CAN in T1DM patients are still missing.

Materials and methods: The study included 54 T1M subjects with and without CAN and 27 healthy, age-correlated volunteers, as a control group. The CAN prevalence was assessed using Ewing test. Expression analysis of human miRNAs was performed using the TaqMan Low- Density Arrays (TLDAs) Panel v3.0 (Applied Biosystems). Differentially and significant (p<0.05) expressed miRNA were uploaded into the DIANA-mirPath v.3, for Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathway analysis.

Results: Our study revealed a significantly upregulated expression of miR-190b, miR-520d-3p and miR-30a-5p in both CAN and T1DM groups comparing to control. Nevertheless, the miRNAs expression within T1DM patients with/ without CAN did not differ.

Discussion: All of significantly altered miRNA are involved in axon guidance pathway, playing a role in neuron regeneration and, as a result of impaired function, neuropathy. Additional significantly regulated miR-30a-5p downregulates the expression of Beta/ NeuroD gene, which role in the pathogenesis of diabetes mellitus is well documented.

Conclusion: Our study, for the first time, showed the potential correlation between epigenetic mechanisms and CAN, stressing that mi-30a-5p might be a new tool for early diagnosis and potentially therapeutic target of T1DM.

Keywords: Cardiac Autonomic Neuropathy; Diabetes Type 1; Epigenetics Mechanisms; Mirna

Abstract| Introduction| Materials and Methods| Results| Discussion| Conflict of Interest| Ethical Approval| Funding| Author Contributions| References|